These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28988693)

  • 1. Circulating CD8
    Song Q; Ren J; Zhou X; Wang X; Song G; Hobeika A; Yuan Y; Lyerly HK
    Cytotherapy; 2018 Jan; 20(1):126-133. PubMed ID: 28988693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.
    Song G; Wang X; Jia J; Yuan Y; Wan F; Zhou X; Yang H; Ren J; Gu J; Lyerly HK
    Cancer Immunol Immunother; 2013 Jun; 62(6):1123-30. PubMed ID: 23604172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion.
    Song QK; Ren J; Zhou XN; Wang XL; Song GH; Di LJ; Yu J; Hobeika A; Morse MA; Yuan YH; Yang HB; Lyerly HK
    Oncotarget; 2015 Dec; 6(38):41350-9. PubMed ID: 26462021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
    Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
    J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients.
    Geng R; Tang H; You T; Xu X; Li S; Li Z; Liu Y; Qiu W; Zhou N; Li N; Ge Y; Guo F; Sun Y; Wang Y; Li T; Bai C
    Front Immunol; 2023; 14():1125876. PubMed ID: 36969245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELEVATED PD-1/CD28 RATIO RATHER THAN PD-1 EXPRESSION IN CD8+ T CELLS PREDICTS NOSOCOMIAL INFECTION IN SEPSIS PATIENTS: A PROSPECTIVE, OBSERVATIONAL COHORT STUDY.
    Zhong W; Li J; Li D; Li X; Liu M; Zhang T; Huang J; Huang G; Zeng H; Zhou M; Jiang W
    Shock; 2022 Aug; 58(2):111-118. PubMed ID: 36166194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer.
    Liu X; Cheng X; Xie F; Li K; Shi Y; Shao B; Liang X; Wan F; Jia S; Zhang Y; Liu Y; Li H
    Br J Cancer; 2024 Jun; 130(10):1599-1608. PubMed ID: 38519706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Circulating CD28 Negative Suppressor T Cells and Memory B Cells in Patients with Breast Cancer.
    Zahran AM; Shaltout AS; Fakhry H; Khallaf SM; Abdel Fattah ON; Temerik DF; Rayan A
    Iran J Immunol; 2020 Jun; 17(2):95-110. PubMed ID: 32602464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.
    Alvarez-Fernández C; Escribà-Garcia L; Vidal S; Sierra J; Briones J
    J Transl Med; 2016 Jul; 14(1):214. PubMed ID: 27435312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer.
    Kini Bailur J; Gueckel B; Pawelec G
    J Transl Med; 2016 May; 14(1):151. PubMed ID: 27234566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer.
    Liu C; Hu Q; Hu K; Su H; Shi F; Kong L; Zhu H; Yu J
    J Transl Med; 2019 Apr; 17(1):120. PubMed ID: 30971280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer.
    Onyema OO; Decoster L; Njemini R; Forti LN; Bautmans I; De Waele M; Mets T
    Anticancer Res; 2015 Mar; 35(3):1481-9. PubMed ID: 25750301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral cytotoxic T lymphocyte predicts first-line progression free survival in HER2-positive advanced breast cancer.
    Liu XR; Yu JJ; Song GH; Di LJ; Jiang HF; Yan Y; Liang X; Zhang RY; Ran R; Wang J; Bai H; Jia SD; Li HP
    Breast; 2021 Feb; 55():7-15. PubMed ID: 33296767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
    Lafrenie RM; Speigl L; Buckner CA; Pawelec G; Conlon MS; Shipp C
    Clin Breast Cancer; 2019 Dec; 19(6):433-442. PubMed ID: 31383605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased level of peripheral CD8
    Li Y; Qian T; Zhao H; Zhang Z; Ming Y; Qiao G; Liu J
    Future Oncol; 2020 Nov; 16(32):2611-2617. PubMed ID: 32820651
    [No Abstract]   [Full Text] [Related]  

  • 16. Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
    Bailur JK; Gueckel B; Derhovanessian E; Pawelec G
    Breast Cancer Res; 2015 Mar; 17(1):34. PubMed ID: 25849846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8+ subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence.
    Fagnoni FF; Lozza L; Zibera C; Zambelli A; Ponchio L; Gibelli N; Oliviero B; Pavesi L; Gennari R; Vescovini R; Sansoni P; Da Prada G; Robustelli Della Cuna G
    Immunology; 2002 May; 106(1):27-37. PubMed ID: 11972629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
    Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
    J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peripheral blood leukocyte phenotype in patients with breast cancer: effect of doxorubicin/paclitaxel combination chemotherapy.
    Melichar B; Tousková M; Dvorák J; Jandík P; Kopecký O
    Immunopharmacol Immunotoxicol; 2001 May; 23(2):163-73. PubMed ID: 11417845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8
    Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.